Home » Headlines » Currently Reading:

Morning Headlines 11/29/16

November 28, 2016 Headlines No Comments

Republicans reach deal to pass Cures Act by end of year, but Democrats pushing for changes

The House will vote Wednesday on a final version of the 21st Century Cures Act, a $6.3 billion piece of legislation that will target opioid addiction, fund Obama administration research programs for the next 10 years, and speed federal approval of new drugs and devices.

CMS’ star ratings for hospitals linked to social, economic factors

A new JAMA study finds that a hospital’s CMS star rating is “heavily influenced by its location’s socio-economic conditions,” reinforcing longstanding concerns voiced by industry stakeholders.

Theranos Sued for Alleged Fraud by Robertson Stephens Co-Founder Colman

Lawsuits continue to pile up for Theranos, with investment firm Robertson Stephens & Co founder Robert Colman accusing the company of making false and misleading claims about operations and technology during its investment talks.

HIMSS17: Stealing Your Life

Former conman and world renown authority on forgery and fraud, Frank Abagnale, will speak at HIMSS17 at a session called Stealing Your Life that will address data breaches and identify theft within the healthcare industry.

View/Print Text Only View/Print Text Only


HIStalk Featured Sponsors

     







Subscribe to Updates

Search


Loading

Text Ads


Report News and Rumors

No title

Anonymous online form
E-mail
Rumor line: 801.HIT.NEWS

Tweets

Archives

Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reader Comments

  • FRANK POGGIO: Shows to go ya...answering black and white Jeopardy questions is a far cry from the massive grey area of medicine/pharma...
  • Number Cruncher: You are right AC. The cost is seriously underestimated here. Just looking at the numbers - $1 B for 5 years = $200 M ...
  • Abraham Van Helsing: Re Theranos. Will be interesting to follow the saga. As I and others had noted going back 2+ years, something was obvi...
  • Prof. Moriarty: Re: Watson pull out. I've not been directly involved with this product, but from its beginning I have always seen Watso...
  • mih: Of course they can, and for much much cheaper. But why would they do it? Existing arrangement works for everyone in the ...
  • Andrew M. Harrison: Thanks for (actually) reading our paper. I enjoyed the story of your friend, as well as the translation of numbers to em...
  • Mike: I would love to see this type of discussion around Blockchain. It is being hyped heavily currently. Yet, I wonder how we...
  • Brian Too: Just slightly off-topic, but I recently heard an interesting downtime rule-of-thumb: Every hour of downtime requires 2 ...
  • James E Thompson: AI in particular isn't disruptive until it can offer an effective alternative against which a go/no-go decision makes se...
  • Former Newspaper Guy: I applaud your attention to grammar and style. In high school, I worked for the local newspaper in the sports department...

RSS Industry Events

  • An error has occurred, which probably means the feed is down. Try again later.

Sponsor Quick Links